Inhibition of the aurora kinase a protein may help overcome lung cancer resistance to KRAS inhibition
In preclinical models, combining an investigational Aurora Kinase A (AURKA) inhibitor with a KRAS inhibitor…
Browsing: Lung Cancer
Most cases of never-smokers’ lung cancer treatable with mutation-targeting drugs
Despite smoking’s well-known role in causing lung cancer, a significant number of patients who develop…
ESMO 2021: IMpower010 Study
Highlights on patterns of relapse in non-small cell lung cancer to atezolizumab vs best supportive…
ESMO 2021: Immune checkpoint inhibitor atezolizumab as a potential game-changer in the treatment of early-stage NSCLC
With an estimated 2.2 million new cancer cases and 1.8 million deaths globally, lung cancer…
Classifying EGFR mutations by structure and function offers better way to match non-small cell lung cancer patients to treatments
Researchers from The University of Texas MD Anderson Cancer Center, USA, have discovered that grouping…
Industry support to probe fundamental questions in lung cancer
Peter Mac scientists hope to gain new insights into what drives lung cancer, and how…
WCLC 2021: UK lung cancer trial shows screening at-risk groups lowers mortality rates
Results from the UK Lung Screening Trial (UKLS), the first lung cancer CT screening trial…
Artificial intelligence could help diagnose lung cancer a year earlier
An artificial intelligence (AI) program can spot signs of lung cancer on CT scans a…
Study illuminates origins of lung cancer in never smokers
A genomic analysis of lung cancer in people with no history of smoking has found…
Novel AI blood testing technology can ID lung cancers with high accuracy
A novel artificial intelligence blood testing technology developed by researchers at the Johns Hopkins Kimmel…